Veto -- or threat thereof -- prevails over majority as 102nd Congress adjourns.
D000028:Abortion, Induced; D000569:Americas; D001943:Breast Neoplasms; D002487:Centers for Disease Control and Prevention, U.S.; D002689:Chlamydia; D003365:Costs and Cost Analysis; D019049:Developed Countries; D003933:Diagnosis; D004194:Disease; D004219:District of Columbia; D004467:Economics; D005069:Evaluation Studies as Topic; D005321:Extraembryonic Membranes; D005193:Family Planning Services; D005333:Fetus; D005376:Financial Management; D005380:Financing, Government; D006076:Government; D006077:Government Agencies; D007239:Infections; D007348:Insurance, Health; D007391:International Cooperation; D007878:Legislation as Topic; D008389:Marketing of Health Services; D008403:Mass Screening; D008484:Medicaid; D008889:Military Personnel; D009369:Neoplasms; D009656:North America; D009938:Organizations; D004364:Pharmaceutical Preparations; D011057:Politics; D011155:Population Control; D011247:Pregnancy; D011632:Public Assistance; D011640:Public Policy; D012098:Reproduction; D012106:Research; D012749:Sexually Transmitted Diseases; D013812:Therapeutics; D014481:United States; D014492:United States Public Health Service; D002583:Uterine Cervical Neoplasms
D004364:Pharmaceutical Preparations
Abortion Law; Abortion, Induced; Americas; Breast Cancer; Cancer; Cdc; Cervical Cancer; Chlamydia; Critique; Developed Countries; Diseases; District Of Columbia; Drugs; Economic Factors; Examinations And Diagnoses; Family Planning; Fertility Control, Postconception; Fetal Membranes; Fetal Tissue; Fetus; Financial Activities; Financing, Government; Foreign Aid; Government; Government Agencies; Health Insurance; Infections; Legislation; Marketing; Medical Assistance, Title 19; Military Personnel; Neoplasms; North America; Northern America; Organizations; Policy; Political Factors; Population Control; Population Policy; Population Programs; Pregnancy; Pricing; Public Assistance; Reproduction; Reproductive Tract Infections; Research Activities; Research Methodology; Screening; Sexually Transmitted Diseases; Social Policy; Treatment; United States; Usphs